Nel corso della quinta BAL TALK abbiamo intervistato Maurizio Bonati, medico dell’IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Medico, Stefano Vicari, neuropsichiatra infantile dell’Ospedale Pediatrico Bambino Gesù, e Laura Reali, pediatra di famiglia. Tra i temi trattati: l’appropriatezza nell’uso degli psicofarmci, la dsiponibilità dei genitori ad accettare un approccio cognitivo-comportamentale o la prescrizione di psicofarmaci; quale dovrebbe essere l’iter ideale nella presa in carico e cosa succede in realtà. Dalle risposte emergono le grandi potenzialità della neuropsichiatria infantile italiana e le difficoltà a venire incontro a una richiesta di assistenza sproporzionata alle risorse disponibili.
Un percorso partecipato evidence-based
Intervista a Maurizio Bonati, medico, IRCCS Istituto Mario Negri
Disagio psichico: ci vuole una rete
Intervista a Laura Reali, pediatra di famiglia
La migliore cura possibile
Intervista a Stefano Vicari, neuropsichiatra infantile, Ospedale Pediatrico Bambino Gesù
Currie JM et al. Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the covid-19 pandemic. JAMA Netw Open 2021;4(4):e216147.
Marson A, Burnside G, Appleton R, et al.; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;397(10282):1375-1386.
Marson A, Burnside G, Appleton R, et al.; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;397(10282):1363-1374.
Zichi C et al. Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. Eur j Canc 2021;149:49-60.
Seidler AN et al.; on behalf of the International Liaison Committee On Resuscitation Neonatal Life Support Task Force. Umbilical cord management for newborns <34 weeks' gestation: a meta-analysis. Pediatrics 2021; 147 (3) e20200576.
Gabrhelík R et al. Cannabis use during pregnancy and risk of adverse birth outcomes: a longitudinal cohort study. Eur Addict Res 2020. doi: 10.1159/000510821e
Ouldali N et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. February 1, 2021. Epub ahead of print. doi:10.1001/jama.2021.0694
Freedman RA et al. Individualizing surveillance mammography for older patients after treatment for early-stage breast cancer: multidisciplinary expert panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. Published online January 28, 2021. doi:10.1001/jamaoncol.2020.7582
Fontanella CA et al. Association of cannabis use with self-harm and mortality risk among youths with mood disorders. JAMA Pediatr. Published online January 19, 2021. doi:10.1001/jamapediatrics.2020.5494